Logo

Course

2021 Annual New York State Hepatitis C and Drug User Health Conference - Antiracist Health Care Approaches for People who Use Drugs and/or Living with Hepatitis C: Time for a New Paradigm. (Day 1)

Details

Published Date: 01/07/2022

Expiration Date: 09/14/2024

CE Credit: No CE

Description

This two-part training highlights antiracist practices and health equity in hepatitis C and drug user health care and treatment. Part One includes the following five sessions: Antiracism and Harm Reduction; Priority Outcomes for Patient-centered Substance Use Disorder; Tele-Harm Reduction; Structural Racism and Hepatitis C; and Hepatitis C Treatment Updates in Specific Populations.

Disclaimer

Effective June 27, 2023 the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced a one-time requirement of 8 hours of training on the treatment and management of patients with opioid or other substance use disorders for practitioners who are applying for or renewing their DEA license. This 1-hour ACCME-accredited course meets the DEA/SAMHSA requirement.

Presenter(s)

Monique Tula,

Monique Tula is the Executive Director of Harm Reduction Coalition, a national advocacy and capacity-building organization that promotes the health and dignity of people affected by drug use. Previously, she was the Vice President of Programs with AIDS United where she oversaw the grant making and technical assistance portfolios. With more than 20 years of experience in the non-profit sector, Ms. Tula has devoted her career to harm reduction advocacy and infrastructure development of community-based organizations.

Hansel E. Tookes III,MD, MPH

Hansel Tookes III, MD, MPH is an Associate Professor in the Department of Medicine, University of Miami Miller School of Medicine and an attending physician, Division of Infectious Diseases, Jackson Memorial Hospital. Dr. Tookes joined the faculty of the University of Miami Miller School of Medicine in the Division of Infectious Diseases after completing his residency in Internal Medicine at Jackson Memorial Hospital. He is the Principal Investigator of the UM Harm Reduction Research Group, which houses the IDEA Exchange, Miami’s needle exchange program – the first of its kind in Florida.

Julius Wilder, MD, PhD

Julius Wilder, MD, PhD is an Assistant Professor of Medicine at Duke University School of Medicine. Dr. Wilder has an appointment with the Duke Clinical Research Institute and a secondary appointment with the Department of Sociology at Duke. He has authored several peer-reviewed articles in journals such as JAMA, Hepatology, and Liver Transplantation. He is Chair for the Duke Department of Medicine Diversity, Equity, Inclusion, and Anti-Racism Committee, and is Co-Director for the Duke Community Engagement Research Initiative. Dr. Wilder is a principal investigator on multiple clinical trials and has received research awards for his work on social determinants of disparities in gastroenterology and hepatology.

Tatyana Kushner,MD, MSCE

Tatyana Kushner, MD, MSCE is Associate Professor in the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai here in New York, with a joint appointment in the department of Obstetrics and Gynecology. Dr. Kushner’s clinical and research interests focus on clinical predictors, epidemiological trends and outcomes in viral hepatitis and in liver disease during pregnancy. Her clinical practice encompasses the full spectrum of liver disease from non-alcoholic steatohepatitis (NASH) to cirrhosis and decompensated liver disease. She is a member of the AASLD/IDSA HCV Guidance committee, advisor to the CDC Coalition for Global Hepatitis Elimination Tip-HepC Registry and advisor to the Hepatitis C Mentor and Support Group.

Matthew Akiyama,MD, MSc

Matthew. Akiyama, MD, MSc is an Associate Professor of Medicine and Clinician-Investigator at Albert Einstein College of Medicine and Montefiore Medical Center. In addition to providing care and treatment to people living with HIV, HCV, and substance use disorders, Dr. Akiyama conducts research focusing on HCV among socioeconomically marginalized populations. Dr. Akiyama is the recipient of a K99/R00 award from the National Institute on Drug Abuse to develop and test an innovative strategy to improve linkage to and retention in HCV treatment among individuals recently released from jail. He is also the recipient of an Avenir Award from the National Institute on Drug Abuse focused on HCV transmission networks among people who inject drugs. 

Andrea Acevado,MD

Andrea Acevedo, PhD is an Assistant Professor in the Department of Community Health at Tufts University. She has over 15 years of experience in health services research, most of which has been on services for substance use disorders. Much of her research has involved understanding inequities in treatment for substance use disorders, particularly those related to race/ethnicity.

Dr. Acevedo received her Ph.D. in Social Policy with a concentration in behavioral health services and policy from Brandeis University, and her Masters' in Health and Social Behavior from the Harvard School of Public Health.

Orla Kennedy,

Orla Kennedy, Senior Policy Analyst, Substance Use Disorder Program, Community Catalyst

Leah Hill, M.Ed, CASAC-T

Leah Hill, Clinical Engagement Special, University of Rochester, Strong recovery program

Ivette Chavez-Gonzalez,

Ivette Chavez Gonzalez, Peer Outreach Worker

Jennifer Yiengst,

Jennifer Yiengst, Peer Exchange Worker Evergreen Health

Learning Objectives

  • Discuss health equity in hepatitis C and drug user health care and treatment.
  • Describe how the lived experience of individuals relates to the development of an antiracist framework within drug user health.
  • Recognize methods for New York State medical providers' to increase their capacity to provide hepatitis C treatment and health care for people who use drugs within an antiracist framework.
  • Identify and disseminate best practices among hepatitis C and drug user health medical providers in New York State.

Continuing Education Credit Information